COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Simcere Pharmaceutical Group

Innovation-led pharmaceutical company developing and commercializing therapies for oncology, neurology and autoimmune disease.

TICKER2096.HK

HEADQUARTERSNanjing, China

STAGEApproved

ACTIVE TRIALS19

Therapeutic areas

OncologyNeurologyAutoimmune

Selected products and programs

sanbexinSIM0237

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Phase 3 · Recruiting · Refractory Metastatic Colorectal Cancer

A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Participants

Phase 1 · Recruiting · Health, Subjective

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

Phase 1 · Recruiting · Healthy Adult Participants

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Phase 1 · Recruiting · Non-Muscle-Invasive Bladder Cancer (NMIBC)

A Phase I Study of SIM0388 in Participants With Malignant Ascites.

Phase 1 · Recruiting · Malignant Ascites

Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors

Phase 1 · Recruiting · Advanced Solid Tumors

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/simcere-pharmaceutical-group/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record